Chesterfield, MO, United States of America

Thomas L O'Donohue

This inventor holds 4 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, G.d. Searle & Company, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1986-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas L O'Donohue. Retrieved from https://idiyas.com/inventor/thomas-l-o-donohue

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Silver Spring, MD (US) (1986 - 1988)
  • Chesterfield, MO (US) (1995 - 1997)

Company Filing History:


Years Active: 1986-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Thomas L O'Donohue: Innovator in Neurotoxic Injury Treatment

Introduction

Thomas L O'Donohue is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of neurotoxic injury treatment, holding a total of 4 patents. His work focuses on developing compounds and methods to mitigate brain damage associated with critical medical conditions.

Latest Patents

O'Donohue's latest patent involves N-(1-thienylcycloalkyl)alkenylamines for the treatment of neurotoxic injury. This innovative approach describes compounds, compositions, and methods aimed at controlling brain damage that typically follows events such as stroke, cardiac arrest, or perinatal asphyxia. The treatment includes the administration of an N-(1-thienylcycloalkyl)alkenylamine compound, which acts as an antagonist to inhibit excitotoxic actions at major neuronal excitatory amino acid receptor sites. The compounds of most interest are defined by specific formulas, where R groups represent various chemical structures.

Career Highlights

Throughout his career, O'Donohue has worked with prominent organizations, including the United States of America as represented by the Department of Health and G.D. Searle & Company. His innovative work has contributed to advancements in medical treatments and has the potential to improve patient outcomes in critical situations.

Collaborations

O'Donohue has collaborated with notable individuals in his field, including Kenner C Rice and Arthur E Jacobson. These partnerships have likely enhanced the development and application of his innovative ideas.

Conclusion

Thomas L O'Donohue is a distinguished inventor whose work in neurotoxic injury treatment showcases his commitment to advancing medical science. His patents and collaborations reflect a dedication to improving health outcomes for individuals facing severe medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…